Greater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres

Size: px
Start display at page:

Download "Greater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres"

Transcription

1 Greater Manchester Commissioning Hub: Cancer Programme The ACE Programme Wave 2 Multidisciplinary Diagnostic Centres

2 Background / Context GM Pilot focuses on 2 areas of Greater Manchester: Oldham South Manchester

3 Flagship patient 67 year old female Attended for analgesia after knee replacement Weight loss 52kg to 45kg Smoker No other symptoms Screening bloods normal 7 referral pathways

4 88 referrals reviewed Results of Notes Audit All referred to gastroenterology 11 would qualify for vague symptoms pathway 2 cancers diagnosed- pancreatic and renal. Presenting symptoms: 5 weight loss, 5 vague abdominal pain/ nausea/ bloating, 1 persistent hip pain Before yes/ no diagnosis: Hospital visits ranged from 3 to 5 visits, 2 presented in A&E Times to diagnosis ranged from 2-6 weeks

5 Pathway Design Development of a clinically agreed pathway for patients with non-specific but concerning symptoms Agreed primary care triage tests and symptom checklist Referral form and GP guide developed

6 Referral Criteria The reason I am concerned this patient has cancer is.. Example symptoms to investigate through this route (non-exhaustive list) Decreased appetite Non-specific abdominal Persistent pain pain Nausea Lymphadenopathy Unexplained DVT Non-specific iron Hepatomegaly Continued patient or deficiency anaemia family concern Fatigue Splenomegaly GP concern Weight loss Bloating

7 Exclusion Criteria Some symptoms point towards a specific cancer. These should be investigated or referred in accordance with the NICE NG12 guideline and not considered for this pathway: Post-menopausal bleeding Melaena Shortness of breath Abnormal vaginal bleeding Dysphagia Cough Rectal bleeding Haematemesis Haemoptysis Altered Bowel habits Haematuria

8 Primary Care Urgent Investigations Urgent CXR: within 1 working day of the GP appointment. Urinalysis: same-day Urgent blood test: including FBC, U&E, LFT, Bone profile, TFT, LDH, PV/CRP, Ferritin, Glucose, HbA1c, Mononucleosis test, Coeliac screen, Myeloma screen. Also PSA (male only), beta- HCG (male only), CA125 (female only).

9 Multidisciplinary Diagnostic Clinics Appointments offered within 14 days Navigator key to co-ordination of appointment One-stop clinic model Consultant or specialist nurse appointment Diagnostic tests: CT thorax abdomen pelvis OGD Most patients will receive the results on the same day

10 Results South Manchester seen 187 patients Oldham seen 115 patients 61% of practices have used the service

11 Top Symptoms South No. of cases Oldham No. of cases Abdominal pain: Weight loss: Nausea / appetite loss: Fatigue: GP gut feeling: 55 90

12 Average No. of secondary care consultations: Diagnostic Activity South Diagnostic tests CT 130 OGD 55 Days from referral to (cancer) diagnosis: (as per 28 days target definition) 1 1 Oldham CT 112 OGD days (median) 21 days (median)

13 Diagnoses MDC Site South Oldham Cancer conversion: 13/187 (6.95%) 17/115 (14.8%) Early stage I & II: 6/13 (46 %) 2/17 (11.8%) What did we expect? More cancers at early stage Non-cancer diagnoses: (diagnosed by MDC) Non cancer 112/187 (53%) All tests normal 57/187 (33.15%) Under investigation 5/187) (2.67%) Non cancer 40/115 (34.78%) All test normal 48/115 (41.73%) MDC Site South Oldham Cancer type & number (summary both sites) 1 Pancreatic Cancer 1 Metastatic Breast Cancer 1 CUP 1 Hodgkins lymphoma 4 Lung Cancer 3 Prostate Cancer 1 Renal cell Cancer 1 Metastatic Melanoma 2 stomach cancer 4 Lung cancer 1 Bladder cancer 1 Non Hodgkins Lymphoma 2 Colon cancer 2 Renal Cancer 2 HPB cancer 1 Prostate cancer 1 Liver cancer What did we find? Advanced cancers Conversion rate to mirror the Danish model -

14 Verdict so far All went smoothly very impressed well done NHS Just keep doing what you do BRILLIANT Everything worked well today a very good system and helps people to get help sooner Speed in which I was seen in each area was great, as was how quick the results were back. The Nurse and Navigator were very supportive. Liked one to one contact with the Specialist Nurse and Navigator. Clear explanations of test and the programme throughout the day. Ensuring patients were took to the correct department could not have been more helpful and supportive.

15 GP feedback Unusual case -?skin metastases Where to send him - dermatology, plastics, general surgery? One initial appointment for the patient -he felt extremely well looked after and informed Clear information back to me very quickly - it is always a little embarrassing when the patient expects us to have the information from the hospital If this clinic had not been there I am certain he would have bounced around the system for some time before we got the answer - this would have been difficult for him and I would most probably been chasing up appointments

16 Next Steps Rollout across Greater Manchester Referrals from Emergency Departments MUO patients Secondary care triage of all eligible patients

17 Questions?

Cancer of Unknown Primary Service

Cancer of Unknown Primary Service Cancer of Unknown Primary Service Dr Maurice Fernando Consultant In Specialist Palliative Care and CUP lead Doncaster and Bassetlaw Hospitals NHS FT Wakefield meeting -14-07-2016 CUP service CUP MDT

More information

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios How to use the case scenarios The case scenarios can be used in a training

More information

Accelerate, Coordinate, Evaluate (ACE) Programme

Accelerate, Coordinate, Evaluate (ACE) Programme Emerging Multidisciplinary Diagnostic Centre (MDC) models and design principles ACE Wave 2: exploring the concept of MDC-based pathways ACE Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis

More information

Accelerate, Coordinate, Evaluate (ACE) Programme

Accelerate, Coordinate, Evaluate (ACE) Programme Emerging multidisciplinary diagnostic centre (MDC) models and design principles ACE wave 2: exploring the concept of MDC-based pathways ACE Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis

More information

The ACE Programme. Multidisciplinary Diagnostic Centres (Wave 2) Cancer Cascade Reading, 22nd November 2018

The ACE Programme. Multidisciplinary Diagnostic Centres (Wave 2) Cancer Cascade Reading, 22nd November 2018 The ACE Programme Multidisciplinary Diagnostic Centres (Wave 2) Cancer Cascade Reading, 22nd November 2018 Veronique Poirier ACE Programme Data Manager Title ACE Programme overview An early diagnosis initiative

More information

Cancer of Unknown Primary (CUP) Protocol

Cancer of Unknown Primary (CUP) Protocol 1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date

More information

Accelerate, Coordinate, Evaluate (ACE) Programme

Accelerate, Coordinate, Evaluate (ACE) Programme Emerging multidisciplinary diagnostic centre (MDC) models and design principles ACE wave 2: exploring the concept of MDC-based pathways Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis

More information

Multidisciplinary Diagnostic Centre (MDC) based pathways for patients with non-specific but concerning symptoms

Multidisciplinary Diagnostic Centre (MDC) based pathways for patients with non-specific but concerning symptoms Multidisciplinary Diagnostic Centre (MDC) based pathways for patients with non-specific but concerning symptoms Interim report May 2018 Version 2.4 Accelerate, Coordinate, Evaluate (ACE) Programme An early

More information

Clinical Biochemistry Department City Hospital

Clinical Biochemistry Department City Hospital Cancer Biochemistry and Tumour Markers Clinical Biochemistry Department City Hospital In this lecture Cancer basics Definition of Tumour Marker (TM) What is the perfect TM? History of TMs Examples of TMs

More information

North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO)

North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO) North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO) UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Original Prepared by NMcL April 2016

More information

Identifying distinguishing features of the MDC model within the five ACE projects

Identifying distinguishing features of the MDC model within the five ACE projects Identifying distinguishing features of the MDC model within the five ACE projects Context: The ACE Programme (Wave 2) has been working with five projects across England to trial and evaluate the concept

More information

Early Diagnosis: Serious but non-specific symptom pathway

Early Diagnosis: Serious but non-specific symptom pathway Early Diagnosis: Serious but non-specific symptom pathway Lily Megaw Becky Gokce Karen Fitzgerald Geraint Jones Luigi de Michele Arun Takhar Introduction Lily Megaw This is a five year programme Based

More information

Prevention of Bowel Cancer: which patients do I send for colonoscopy?

Prevention of Bowel Cancer: which patients do I send for colonoscopy? Prevention of Bowel Cancer: which patients do I send for colonoscopy? Dr Chris Groves Consultant Gastroenterologist and Honorary Senior Lecturer St George s Hospital and Medical School Director, SW London

More information

Recognition and Referral of Suspected Cancer - NICE guidance and local initiatives

Recognition and Referral of Suspected Cancer - NICE guidance and local initiatives Recognition and Referral of Suspected Cancer - NICE guidance and local initiatives Dr. Louise Merriman GP Clinical Lead for South Yorkshire, Bassetlaw and Derbyshire Cancer Alliance Topics to be covered

More information

FIT for symptomatic patients. Facilitator name

FIT for symptomatic patients. Facilitator name FIT for symptomatic patients Facilitator name Context colorectal cancer Colorectal cancer in the UK 41,804 new cases in 2015 15,903 deaths in 2014 Fourth most common cancer Second most common cause of

More information

OCCG Board Meeting. Oxfordshire Clinical Commissioning Group. Date of Meeting: 30 November 2017 Paper No: 17/80

OCCG Board Meeting. Oxfordshire Clinical Commissioning Group. Date of Meeting: 30 November 2017 Paper No: 17/80 OCCG Board Meeting Oxfordshire Clinical Commissioning Group Date of Meeting: 30 November 2017 Paper No: 17/80 Title of Paper: SCAN Pathway Project Update Paper is for: (please delete tick as appropriate)

More information

Improving diagnostic pathways for patients with vague symptoms

Improving diagnostic pathways for patients with vague symptoms Improving diagnostic pathways for patients with vague symptoms Executive summary Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis of cancer initiative supported by: NHS England, Cancer

More information

Cancer: NICE (symptom based)- what s new November 2016

Cancer: NICE (symptom based)- what s new November 2016 Cancer: NICE (symptom based)- what s new November 2016 Dr Katy Gardner, Dr Cathy Hubbert, Macmillan GP Cancer Leads, Liverpool CCG See stalls for more information and local pathways (Cheshire & Merseyside)

More information

Introduction. Please note the toolkit aims to share learning and good practice, but it is, of necessity, brief in nature.

Introduction. Please note the toolkit aims to share learning and good practice, but it is, of necessity, brief in nature. July 2015 edition Introduction The Rapid Referral guidance toolkit has been produced by Macmillan Cancer Support. It contains the NICE referral guidelines for suspected cancer (2015 update) with additional

More information

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care Bowel cancer risk in the under 50s Greg Rubin Professor of General Practice and Primary Care Prevalence of GI problems in the consulting population Thompson et al, Gut 2000 Number of patients % of patients

More information

South Yorkshire, Bassetlaw and North Derbyshire Cancer Alliance

South Yorkshire, Bassetlaw and North Derbyshire Cancer Alliance South Yorkshire, Bassetlaw and North Derbyshire Cancer Alliance Patient Details: Patient Name Address DOB Home Tel. No. Mobile Tel. No. Preferred Tel. No. Main Spoken Language Transport needed? Registered

More information

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018 SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018 Dr Peter Hutchison, Chair of Review Group WHAT & WHY? Scottish Cancer Referral Guidelines 2014 Scottish Primary Care Cancer Group identified need for some

More information

Transforming Cancer Services for London

Transforming Cancer Services for London Programme Director Paul Roche Status Draft Owner Laura Boyd Version 0.4 Author Jennifer Layburn Date 15/05/13 Transforming Cancer Services for London Best Practice Commissioning Pathway for the early detection

More information

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease Refer back to original requester with this paperwork and review previous

More information

Suspected CANcer (SCAN) Pathway Information for patients

Suspected CANcer (SCAN) Pathway Information for patients Suspected CANcer (SCAN) Pathway Information for patients page 2 Your GP has advised you may benefit from investigation via the SCAN pathway. The SCAN pathway is part of a national programme called ACE

More information

Achieving earlier diagnosis of cancer in Lincolnshire. Dr Martin Latham GP Cancer Lead Lincolnshire West CCG February 2018

Achieving earlier diagnosis of cancer in Lincolnshire. Dr Martin Latham GP Cancer Lead Lincolnshire West CCG February 2018 Achieving earlier diagnosis of cancer in Lincolnshire Dr Martin Latham GP Cancer Lead Lincolnshire West CCG February 2018 The state of Lincolnshire Cancer Care Lincolnshire: The worst part of the country

More information

SIGNS, SYMPTOMS AND SCREENING GUIDELINES

SIGNS, SYMPTOMS AND SCREENING GUIDELINES SIGNS, SYMPTOMS AND SCREENING GUIDELINES SIGNS AND SYMPTOMS You may think it s normal, but it could be a sign or symptom of an illness or cancer-related disease. If you are experiencing any of these signs

More information

This information explains the advice about suspected cancer that is set out in NICE guideline NG12.

This information explains the advice about suspected cancer that is set out in NICE guideline NG12. Recognising, investigating and referring people with symptoms of suspected cancer Information for the public Published: 25 June 2015 nice.org.uk About this information NICE guidelines provide advice on

More information

Leeds: Early Diagnosis Project updates

Leeds: Early Diagnosis Project updates Leeds: Early Diagnosis Project updates Cancer Cascade Event, 11 th May 2017 Joanna Bayton-Smith, Macmillan Leeds Cancer Strategy, Programme Manager Objectives: To provide overview of Leeds Cancer Strategy

More information

Cancer of Unknown Primary

Cancer of Unknown Primary Cancer of Unknown Primary Helen Rickards Acute Oncology and Cancer of Unknown Primary CNS 18 th May 2017 Defining CUP Incidence Patient Pathways getting a diagnosis Patient assessment The patient s perspective

More information

Danish Three-Legged Strategy for Early Diagnosis - an integrating approach

Danish Three-Legged Strategy for Early Diagnosis - an integrating approach Danish Three-Legged Strategy for Early Diagnosis - an integrating approach Peter Vedsted Professor, Director Lower 1-year survival in Denmark Local stage for breast or lung cancer % lung cancer in local

More information

Urgent referral for suspected cancer in Scotland

Urgent referral for suspected cancer in Scotland 270 Oncology Urgent referral for suspected cancer in Scotland Cancer is a common problem, but an individual GP may only see about seven to eight new cases of cancer per annum (although they will see many

More information

THAMES VALLEY AUDIT OF PATIENTS DIAGNOSED WITH CANCER FOLLOWING AN EMERGENCY PRESENTATION

THAMES VALLEY AUDIT OF PATIENTS DIAGNOSED WITH CANCER FOLLOWING AN EMERGENCY PRESENTATION THAMES VALLEY AUDIT OF PATIENTS DIAGNOSED WITH CANCER FOLLOWING AN EMERGENCY PRESENTATION Dr Jennifer Yiallouros RCGP and CRUK workshop Brighton, March 2017 Acknowledgements Thames Valley Strategic Clinical

More information

Improving diagnostic pathways for patients with vague symptoms

Improving diagnostic pathways for patients with vague symptoms Improving diagnostic pathways for patients with vague symptoms Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis of cancer initiative supported by: NHS England, Cancer Research UK and

More information

East Kent Summary Guidance suspected cancer referrals and notes GP reference document May 2018

East Kent Summary Guidance suspected cancer referrals and notes GP reference document May 2018 East Kent Summary Guidance suspected cancer referrals and notes GP reference document May 2018 GP INTIATIED DIAGNOSITCS USS Gall Bladder or Liver Fast-track ultrasound to assess for gall bladder or liver

More information

OFFICIAL. Document Status. NHS England INFORMATION READER BOX

OFFICIAL. Document Status. NHS England INFORMATION READER BOX NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Strategy & Innovation Finance Publications Gateway Reference: 07923

More information

Faecal Immunochemical Testing (FIT) for Screening and Symptomatic Patients

Faecal Immunochemical Testing (FIT) for Screening and Symptomatic Patients Faecal Immunochemical Testing (FIT) for Screening and Symptomatic Patients Caroline Addison NE BCSP Hub Director and Consultant Clinical Scientist What is FIT Type of Faecal Occult Blood test Designed

More information

Referral guidelines for suspected cancer

Referral guidelines for suspected cancer Referral guidelines for suspected cancer Understanding NICE guidance information for people who may need a referral, their families and carers, and the public Prepared for second consultation The paragraphs

More information

Faster Cancer Treatment Indicators: Use cases

Faster Cancer Treatment Indicators: Use cases Faster Cancer Treatment Indicators: Use cases 2014 Date: October 2014 Version: Owner: Status: v01 Ministry of Health Cancer Services Final Citation: Ministry of Health. 2014. Faster Cancer Treatment Indicators:

More information

Throwing light on the consequences of cancer and its treatment

Throwing light on the consequences of cancer and its treatment Throwing light on the consequences of cancer and its treatment Lesley Smith Consequences of Treatment Programme Manager at Macmillan Cancer Support & the National Cancer Survivorship Initiative The London

More information

NICE Guidance. Suspected Cancer in Adults COLORECTAL (2WW)

NICE Guidance. Suspected Cancer in Adults COLORECTAL (2WW) NICE Guidance Suspected Cancer in Adults COLORECTAL (2WW) Date of Referral: Short date letter merged Name: Full Name DOB: Date of Birth NHS No NHS Number Attach this form to the e-referral within 24 hours

More information

No. 2 - Persistent Pain or Discomfort in Any Body Area

No. 2 - Persistent Pain or Discomfort in Any Body Area See Your Doctor When Symptoms Occur, and Get Regular Checkups. Experts say that men could benefit greatly by being alert to certain cancer symptoms that indicate a trip to the doctor's office sooner rather

More information

PREOPERATIVE ANAEMIA PATHWAY

PREOPERATIVE ANAEMIA PATHWAY PREOPERATIVE ANAEMIA PATHWAY Surname: Unit No. Forename: DOB: / / Age: NHS Number: Likes to be called: Address: Tel. No. Religion/Spirituality: GP Name: GP Practice: Planned Operation: Postcode: Mobile

More information

ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report

ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY. Phases One and Two Final Report ACE Programme SOMERSET INTEGRATED LUNG CANCER PATHWAY Phases One and Two Final Report July 2017 Introduction This paper presents the learning and actions that have been generated from phase One and Two

More information

REFERRAL GUIDELINES GASTROENTEROLOGY

REFERRAL GUIDELINES GASTROENTEROLOGY REFERRAL GUIDELINES GASTROENTEROLOGY Referral Form: The GP Referral Template is the preferred referral tool (previously known as the Victorian Statewide Referral Form) GP Referral Template This tool is

More information

Cancer Cascade Workshop. DoubleTree by Hilton, Bristol 11 th May 2017

Cancer Cascade Workshop. DoubleTree by Hilton, Bristol 11 th May 2017 DoubleTree by Hilton, Bristol 11 th May 2017 Dr Richard Roope RCGP and Cancer Research UK Cancer Clinical Champion Senior Clinical Advisor Cancer Research UK What s new? Cancer Cascade Workshop What s

More information

PRIORITIES AND CLINICAL EFFECTIVENESS FORUM

PRIORITIES AND CLINICAL EFFECTIVENESS FORUM PRIORITIES AND CLINICAL EFFECTIVENESS FORUM CANCER - GUIDELINES FOR URGENT REFERRAL OF PATIENTS WITH These guidelines are intended as a quick reference for GPs to ensure appropriate referral of those patients

More information

Ovarian Cancer. What you should know. making cancer less frightening by enlightening

Ovarian Cancer. What you should know. making cancer less frightening by enlightening Ovarian Cancer What you should know making cancer less frightening by enlightening ovarian cancer the facts Over 360 cases are diagnosed in Ireland annually It is the 6th most common cancer in women 4

More information

Pancreatic Cancer. Stats, facts and how things can improve. Let s drive earlier diagnosis

Pancreatic Cancer. Stats, facts and how things can improve. Let s drive earlier diagnosis Pancreatic Cancer Stats, facts and how things can improve Ali Stunt, Founder & Chief Executive Pancreatic Cancer Action (and 8 year survivor of pancreatic cancer) Let s drive earlier diagnosis The Pancreas

More information

Haematological Cancer Suspected (Adults & Children)

Haematological Cancer Suspected (Adults & Children) Haematological Cancer Suspected (Adults & Children) Link to NICE guidelines: https://www.nice.org.uk/guidance/ng47 Patient of any age presents with symptoms of possible haematological cancer If 60 years

More information

Cancer Care Kenya Notes for General Practioners:

Cancer Care Kenya Notes for General Practioners: Cancer Care Kenya Notes for General Practioners: Site specific symptoms for detecting cancers at an early stage is given below. Please refer patients for detailed work up. 1. Brain /CNS tumors: Sub acute

More information

Referral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography

Referral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography Referral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography 2019 Released 2019 health.govt.nz Citation: Ministry of Health. 2019. Referral Criteria for Direct Access

More information

The Late Consequences of Cancer Treatment The Impact & Management of the Late Effects of Pelvic Cancer Treatments

The Late Consequences of Cancer Treatment The Impact & Management of the Late Effects of Pelvic Cancer Treatments The Late Consequences of Cancer Treatment The Impact & Management of the Late Effects of Pelvic Cancer Treatments Lesley Smith Consequences of Treatment Programme Manager at Macmillan Cancer Support &

More information

GUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY

GUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY Position Statement produced by BSG, AUGIS and ACPGBI GUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY Introduction In 2011 the Independent Practice

More information

MSCC CARE PATHWAYS & CASE STUDIES. By Michael Balloch Spine CNS

MSCC CARE PATHWAYS & CASE STUDIES. By Michael Balloch Spine CNS MSCC CARE PATHWAYS & CASE STUDIES By Michael Balloch Spine CNS Aims To be familiar with the routes of MSCC prentaion How the guidelines work in practice Routes of presentation Generic intervention Managing

More information

Pancreatic Cancer. An overview for GPs. Let s drive earlier diagnosis. Pancreatic Cancer Action All Rights Reserved

Pancreatic Cancer. An overview for GPs. Let s drive earlier diagnosis. Pancreatic Cancer Action All Rights Reserved Pancreatic Cancer An overview for GPs Pancreatic Cancer Action All Rights Reserved Pancreatic Cancer Action is a UK charity Registration no 1137689 Let s drive earlier diagnosis The Pancreas This image

More information

Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Cancer of Unknown Primary Network Site Specific Group. Clinical Guidelines

Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services. Cancer of Unknown Primary Network Site Specific Group. Clinical Guidelines Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services Cancer of Unknown Primary Network Site Specific Group Revision due: April 2019 Page 1 of 11 VERSION CONTROL THIS IS A CONTROLLED DOCUMENT.

More information

Screening tests. When you need them and when you don t

Screening tests. When you need them and when you don t Screening tests When you need them and when you don t S creening tests help doctors look for diseases when you don t have symptoms. The tests can Screenings find problems early, when they are easier to

More information

Lung Cancer - Suspected

Lung Cancer - Suspected Lung Cancer - Suspected Shared Decision Making Lung Cancer: http://www.enhertsccg.nhs.uk/ Patient presents with abnormal CXR Lung cancer - clinical presentation History and Examination Incidental finding

More information

Prostate Cancer THE BIG 5 CANCERS AFFECTING MEN IN SA IT IS ESTIMATED THAT 1 IN 19 SOUTH AFRICAN MEN WILL DEVELOP PROSTATE CANCER SYMPTOMS SCREENING

Prostate Cancer THE BIG 5 CANCERS AFFECTING MEN IN SA IT IS ESTIMATED THAT 1 IN 19 SOUTH AFRICAN MEN WILL DEVELOP PROSTATE CANCER SYMPTOMS SCREENING #1 Prostate Cancer IT IS ESTIMATED THAT 1 IN 19 SOUTH AFRICAN MEN WILL DEVELOP PROSTATE CANCER Prostate cancer often occurs without any symptoms Symptoms more likely if advanced: Frequent urination, esp

More information

Diagnosing Cancer in Grampian An Academic GP s Perspective

Diagnosing Cancer in Grampian An Academic GP s Perspective Diagnosing Cancer in Grampian An Academic GP s Perspective Dr Peter Murchie Academic Primary Care, Research Group Hilton Edinburgh Carlton 6 th September 2018 A sense of perspective? Douglas Adams The

More information

Lung Cancer and the Cancer Alliance DR JAMES RAMSAY

Lung Cancer and the Cancer Alliance DR JAMES RAMSAY Lung Cancer and the Cancer Alliance DR JAMES RAMSAY Background Lung cancer is the second commonest cancer in the UK (37,000 new cases in England each year). Commonest cause of cancer death (28,500 people

More information

Richard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead

Richard Watson, Chief Transformation Officer. Dr P Holloway, GP Clinical Lead for Cancer Lisa Parrish, Senior Transformation Lead GOVERNING BODY Agenda Item No. 08 Reference No. IESCCG 18-02 Date. 23 January 2018 Title Lead Chief Officer Author(s) Purpose Cancer Services Update Richard Watson, Chief Transformation Officer Dr P Holloway,

More information

When to Refer for OGD and the Work Up of Upper GI Malignancies

When to Refer for OGD and the Work Up of Upper GI Malignancies When to Refer for OGD and the Work Up of Upper GI Malignancies Dr Hong Qiantai Registrar, Department of Surgery GP Forum 27 May 2017 38 year old female, non-smoker, BMI 29 Works as investment banker Presents

More information

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust Louisa Fleure Advanced Prostate Cancer Clinical Nurse Specialist Guys and St Thomas NHS Trust The classification of advanced prostate cancer The incidence of patients presenting with, or developing advanced

More information

Getting it right: Approaches to promoting earlier diagnosis of cancer The national perspective

Getting it right: Approaches to promoting earlier diagnosis of cancer The national perspective Getting it right: Approaches to promoting earlier diagnosis of cancer The national perspective Housekeeping Toilets Fire alarm Tea and Coffee Wifi: MSE-meeting rooms Password: mselondon Twitter - #gettingitright

More information

Notes: Information for Men Receiving Radiation and Hormone Treatments for Prostate Cancer

Notes: Information for Men Receiving Radiation and Hormone Treatments for Prostate Cancer Notes: Information for Men Receiving Radiation and Hormone Treatments for Prostate Cancer Comments, Feedback? Contact Patient and Professional Education 519 685 8742 Email: lrcpeducation@lhsc.on.ca Reviewed

More information

Cancer. University of Illinois at Chicago College of Nursing

Cancer. University of Illinois at Chicago College of Nursing Cancer University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Develop a basic understanding of cancer 2. Describe

More information

Good clinicians in supportive healthcare systems

Good clinicians in supportive healthcare systems Good clinicians in supportive healthcare systems the Danish three-legged strategy for cancer diagnosis 3rd NAEDI Research Conference London 2015 Peter Vedsted Professor Research Centre for Cancer Diagnosis

More information

FBC interpretation. Dr. Gergely Varga

FBC interpretation. Dr. Gergely Varga FBC interpretation Dr. Gergely Varga #1 71 Y/O female, c/o weakness Test Undertaken : FBC (FBC) Sample Type: Whole Blood [ - 26.09.11 14:59] Hb 7.3 g/dl* 12.0-15.5 RBC 3.5 10^12/l * 3.80-5.60 Hct 0.24

More information

Cancer-specific variation in emergency presentation by sex, age and deprivation across 27 common and rarer cancers

Cancer-specific variation in emergency presentation by sex, age and deprivation across 27 common and rarer cancers Cancer-specific variation in emergency presentation by sex, age and deprivation across 27 common and rarer cancers Gary Abel, Jon Shelton, Sam Johnson, Lucy Elliss-Brookes, Yoryos Lyratzopoulos Why worry

More information

LCA Lung Clinical Forum. 21 st October 2014

LCA Lung Clinical Forum. 21 st October 2014 LCA Lung Clinical Forum 21 st October 2014 Welcome Dr Liz Sawicka Chair - LCA Lung Pathway Group Succession planning Dr Kate Haire Consultant in Public Health Medicine, LCA Commissioning Intentions for

More information

National Update: Living With and Beyond Cancer Implementing Strategic Priority 4 of the National Cancer Taskforce

National Update: Living With and Beyond Cancer Implementing Strategic Priority 4 of the National Cancer Taskforce National Update: Living With and Beyond Cancer Implementing Strategic Priority 4 of the National Cancer Taskforce Duleep Allirajah Head of Policy, Macmillan Cancer Support Total Prevalence - now Total

More information

GI cancer. Sharan Pobbathi Rumina Önaç

GI cancer. Sharan Pobbathi Rumina Önaç GI cancer Sharan Pobbathi Rumina Önaç Why is this relevant? One new case per year per GP York slightly below national average Contents/objectives To know the 2ww criteria and where to find them To be aware

More information

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Sarah Burton Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Gynaecological Cancers Cervical Cancers Risk factors Presentation Early sexual activity Multiple sexual partners Smoking Human Papiloma

More information

Outcomes Report: Accountability Measures and Quality Improvements

Outcomes Report: Accountability Measures and Quality Improvements Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.

More information

Initial Weight Loss Consultation with your GP

Initial Weight Loss Consultation with your GP Bariatric Surgery Questionnaire Initial Weight Loss Consultation with your GP This guidance applies to N.H.S. England only. This sheet is to assist you in researching your weight loss surgery options.

More information

Prepared by: Dr Katherine Brown Fir Lea House Whitecross Newquay Cornwall TR8 4LW. Date: 17/10/2016

Prepared by: Dr Katherine Brown Fir Lea House Whitecross Newquay Cornwall TR8 4LW. Date: 17/10/2016 EXPERT MEDICAL REPORT FOR THE COURT ON BREACH OF DUTY Prepared by: Dr Katherine Brown Fir Lea House Whitecross Newquay Cornwall TR8 4LW Date: 17/10/2016 -------------------------------------------------------------------

More information

Western Health Specialist Clinics Access & Referral Guidelines

Western Health Specialist Clinics Access & Referral Guidelines Gastroenterology Specialist Clinics at Western Health: Western Health provides the following Specialist Clinics for patients who require assessment and management of Gastroenterology / Hepatology conditions.

More information

How a fully integrated Acute Oncology Service can benefit the busy medical unit

How a fully integrated Acute Oncology Service can benefit the busy medical unit How a fully integrated Acute Oncology Service can benefit the busy medical unit Dr. Pauline Leonard MD FRCP Consultant Medical Oncologist Whittington Health Over the next 35 mins Briefly remind you of

More information

Pulmonary Embolism Pathway

Pulmonary Embolism Pathway Pulmonary Embolism Pathway Ambulatory Care Pathway Dr. A. Zafar, Dr. A. Rehman, Dr. T. Malik September, 2011. Patient Identification Label Pulmonary Embolism Pathway Clinical History Comments Hospital

More information

Cancer of Unknown Primary

Cancer of Unknown Primary Cancer of Unknown Primary Helen Rickards Acute Oncology and Cancer of Unknown Primary CNS October 2014 Defining CUP Incidence Patient Pathways getting a diagnosis Patient assessment The patient s perspective

More information

Identification and early detection of cancer patients in primary care Marcela Ewing MD, PhD Regionalt Cancercentrum väst Gothenburg Sweden

Identification and early detection of cancer patients in primary care Marcela Ewing MD, PhD Regionalt Cancercentrum väst Gothenburg Sweden Identification and early detection of cancer patients in primary care Marcela Ewing MD, PhD Regionalt Cancercentrum väst Gothenburg Sweden 2018-11-16 Nordiskt möte Diagnostiska Centrum Cancer diagnosis

More information

National Comparative Audit of red cell transfusion in Medical Patients Part Two

National Comparative Audit of red cell transfusion in Medical Patients Part Two National Comparative Audit of red cell transfusion in Medical Patients Part Two Dr. Kate Pendry, Project Clinical Lead John Grant-Casey, Project Manager August 2013 Part One 9216 cases from 181 sites (90%

More information

Information Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West

Information Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West Information Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West The South West Cancer Alliances have been awarded transformation funding to provide access to

More information

Qcancer: symptom based approach to early diagnosis of cancer. Julia Hippisley-Cox, GP, Professor Epidemiology & Director ClinRisk Ltd

Qcancer: symptom based approach to early diagnosis of cancer. Julia Hippisley-Cox, GP, Professor Epidemiology & Director ClinRisk Ltd + Qcancer: symptom based approach to early diagnosis of cancer Julia Hippisley-Cox, GP, Professor Epidemiology & Director ClinRisk Ltd Acknowledgements Co-authors QResearch database EMIS & contributing

More information

6 UROLOGICAL CANCERS. 6.1 Key Points

6 UROLOGICAL CANCERS. 6.1 Key Points 6 UROLOGICAL CANCERS 6.1 Key Points Prostate Cancer Commonest cancer in males in Scotland Approximately 99% of cases occur in men aged > 50 years About 40% of cases present in men aged < 70 years when

More information

Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases

Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases Date: April 2015 Date for review: April 2018 1. Principles The recognised specialist HPB MDT for Greater

More information

ABDOMINAL PAIN (SEE ALSO ABDOMINAL AORTIC ANEURYSM)

ABDOMINAL PAIN (SEE ALSO ABDOMINAL AORTIC ANEURYSM) ABDOMINAL PAIN (SEE ALSO ABDOMINAL AORTIC ANEURYSM) Evaluating abdominal pain is difficult misdiagnosis of this symptom generates more formal complaints than any other clinical mistake made in our department.

More information

Name of Shared Care Agreement: AZATHIOPRINE/6-MERCAPTOPURINE: Oral immunomodulating drugs for inflammatory bowel disease. Reference number: 01/2008

Name of Shared Care Agreement: AZATHIOPRINE/6-MERCAPTOPURINE: Oral immunomodulating drugs for inflammatory bowel disease. Reference number: 01/2008 Name of Shared Care Agreement: AZATHIOPRINE/6-MERCAPTOPURINE: Oral immunomodulating drugs for inflammatory bowel disease. Reference number: 01/2008 Shared care agreement has been developed appropriately

More information

Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122

Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122 Ovarian cancer: recognition and initial management Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Dr Katie Elliott CRUK strategic GP Macmillan GP with NE &C Learning disability Network Assistant Clinical Lead Northern Cancer Alliance

Dr Katie Elliott CRUK strategic GP Macmillan GP with NE &C Learning disability Network Assistant Clinical Lead Northern Cancer Alliance FIT for symptomatic patients Dr Katie Elliott CRUK strategic GP Macmillan GP with NE &C Learning disability Network Assistant Clinical Lead Northern Cancer Alliance AIMS Review National advice Consider

More information

. AREAS OF RESPONSIBILITY FOR SHARED CARE

. AREAS OF RESPONSIBILITY FOR SHARED CARE SHARED CARE GUIDELINE FOR RILUZOLE IN THE MANAGEMENT OF MOTOR NEURONE DISEASE (MND) SPECIFICALLY AMYOTROPHIC LATERAL SCLEROSIS (ALS) INDICATION This shared care guideline has been prepared to support the

More information

Palliative Care Emergencies

Palliative Care Emergencies Palliative Care Emergencies LAURA BARNFIELD What might constitute an emergency in Palliative Care? 1 Palliative Care Emergencies Major haemorrhage Metastatic Spinal Cord Compression (MSCC) Superior Vena

More information

Ovarian cyst, indigestion, constipation, back pain bloating

Ovarian cyst, indigestion, constipation, back pain bloating P ford residence southampton, ny Ovarian cyst, indigestion, constipation, back pain bloating Mar 15, 2017. 33-year-old Fiona thought her bloating and stomach cramps were normal digestion problems. She

More information

PREOPERATIVE ANAEMIA PATHWAY

PREOPERATIVE ANAEMIA PATHWAY PREOPERATIVE ANAEMIA PATHWAY Surname: Patient ID No. Forename: DOB: / / Age: NHS Number: Likes to be called: Address: Tel. No. Religion/Spirituality: Next of Kin: Name GP Name: GP Practice: Planned Operation:

More information

Referral Form CPFT Chronic Fatigue Syndrome / Myalgic Encephalomyelitis Service (CFS/ME) for Adults

Referral Form CPFT Chronic Fatigue Syndrome / Myalgic Encephalomyelitis Service (CFS/ME) for Adults Referral Form CPFT Chronic Fatigue Syndrome / Myalgic Encephalomyelitis Service (CFS/ME) for Adults Please note: Failure to include all Information required may result in your referral being rejected.

More information

The York Faecal Calprotectin Care Pathway for use in primary care. James Turvill

The York Faecal Calprotectin Care Pathway for use in primary care. James Turvill The York Faecal Calprotectin Care Pathway for use in primary care James Turvill NICE guidance: dg11 Faecal calprotectin (FC) testing as an option in adults with recent onset of lower gastrointestinal symptoms

More information

Haematology dilemma s to refer or not to refer?

Haematology dilemma s to refer or not to refer? Haematology dilemma s to refer or not to refer? NWL Pathology GP Study Day Dr Fatts Chowdhury Consultant Haematologist in Transfusion Medicine NHS Blood and Transplant Senior Honorary Clinical Lecturer

More information